Project Details
Description
AIB1 (amplified in breast cancer 1) is a key regulator of the IGF pathway in triple negative breast cancer
| Status | Finished |
|---|---|
| Effective start/end date | 7/27/10 → 12/31/13 |
Funding
- SUSAN G. KOMEN FOR THE CURE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.